Analyst firms · Raymond James · NKTX

Raymond James NKTX price target and rating history

Nkarta Inc. (NKTX) · Health Care

Raymond James rates Nkarta Inc. (NKTX) Strong Buy with a $16 price target, as of its latest action on Aug 14, 2024. It has published 3 rating actions on NKTX since March 2022, including 1 upgrade and 1 downgrade.

Current rating
Strong Buy
Price target
$16
Median target, all firms
Too few
Actions on NKTX
3

Raymond James price target on NKTX

$17$17$162023202420252026
Raymond James price target on NKTX, each point a stated target, March 2022 to August 2024.

Every Raymond James rating on NKTX

How other firms rate NKTX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
H.C. WainwrightBuy$12Nov 2, 2026
TD CowenBuyJun 23, 2026

Questions about Raymond James and NKTX

What is Raymond James's price target for NKTX?
Raymond James's latest stated price target for Nkarta Inc. (NKTX) is $16, from its action on Aug 14, 2024.
What is Raymond James's rating on NKTX?
Raymond James rates NKTX Strong Buy, a bullish rating, as of Aug 14, 2024.
When did Raymond James last change its view on NKTX?
On Aug 14, 2024, Raymond James upgrades to Strong Buy from Outperform, price target $16.

All Raymond James ratingsNKTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.